Oncodesign Precision Medicine Société anonyme (EPA:ALOPM)

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025
Period Ending	Dec 31, 2025
Taxable Services	105.52K
Products Annexed Activities	155.63K
Total	261.15K

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025
Period Ending	Dec 31, 2025
France	261.15K
Total	261.15K

Data Source: S&P Global Market Intelligence Last updated: May 1, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 12, 2026

Data Sources Report a data error